Written by ExiledRoyal
Print this

Wednesday, 21 April 2010

Man-mountain Venus Williams, five times Wimbledon "Ladies" Singles winner, has agreed to become primary ambassador for the fight against Testicular Cancer.

Williams, with an estimated fortune of over 26 million USD, yesterday gave a Press Conference sitting alongside Minister for Sport, Gerry Sutcliffe.

"For too long I've reaped the benefits of my chosen career and now I've decided to give something back. The fight against testicular cancer is something I relate to very closely, and I feel that I have the balls to make a difference."

"It sounds like a real plum job", she quipped, "and I certainly don't expect the sack."

Brother Serena, currently Prostate Champion, said, "I'm really proud of Venus, and look forward to reaching the men's semi's with her. Now that would be a competition! I mean, we're both good looking fellas, and both more than capable of semi's ourselves."

A number of other companies are clamouring to sponsor Venus now, including Gillette Mach 3, Yorkie Bars and Viagra.

Make ExiledRoyal's day - give this story five thumbs-up (there's no need to register, the thumbs are just down there!)

The story above is a satire or parody. It is entirely fictitious.

Do you dream of being a comedy news writer? Click here to be a writer!

More by this writer

View Story
View Story
View Story
View Story
View Story
View Story

Stop - Warning

The story you are trying to access may cause offense, may be in poor taste, or may contain subject matter of a graphic nature.

This story was written as a satire or parody. It is entirely fictitious.

To confirm you have acknowledged this warning, and wish to continue to read the article, please click the following link.

Otherwise, please click here to go back to the home page.


Mailing List

Get Spoof News in your email inbox!


What's 4 plus 1?

6 5 10 22
76 readers are online right now!

Go to top

We use cookies to give you the best experience, this includes cookies from third party websites and advertisers.

Continue ? Find out more